CaREFREE Study (Calorie Restriction, Environment and Fitness: Reproductive Effects Evaluation Study)
- Conditions
- Hormones
- Interventions
- Behavioral: DEABehavioral: NEA
- Registration Number
- NCT02858336
- Lead Sponsor
- National Institute of Environmental Health Sciences (NIEHS)
- Brief Summary
Background:
Functional hypothalamic amenorrhea (functional HA) is a condition where a woman s period stops for a temporary time. This is due to improper function of the hypothalamus. This is the part of the brain that directs the whole reproductive system. Researchers want to learn more about functional HA. They also want to learn how diet, exercise, and other factors may change women s menstrual cycles.
Objective:
To better understand functional HA.
Eligibility:
Healthy women ages 18-28 years old who:
* Have regular periods
* Exercise no more than 4 hours a week
* Had their first period at age 11-14
Design:
Participants will be prescreened over the phone.
Participants will be screened with:
* Blood and urine tests
* Medical history
* Physical exam.
Participants will have 9 or 10 visits over about 3 menstrual cycles. These include:
* Repeat of screening tests
* Questionnaires
* Exercise test
* Resting energy expenditure test: Participants fast overnight before the test. They lie on their back under a canopy for a half hour.
* Body composition test: This is done with a dual energy x-ray absorptiometry (DXA) scan.
* Pelvic ultrasound
* For two full-day visits, an IV is inserted into an arm vein. The IV takes a blood sample every 10 minutes for 8 hours.
Participants will keep logs:
* Menstrual cycle log
* Diet log for three 4-day cycles
Participants will receive test kits to complete at home:
* Daily blood and urine sample
* Ovulation
Participants will take a daily iron supplement. They will wear a wristband that monitors activity 24 hours a day.
Participants will stick to a special diet for two 5-day periods of time. They will complete two 4-day exercise programs....
- Detailed Description
Functional hypothalamic amenorrhea (HA) is a reversible form of hypogonadotropic hypogonadism (HH) that can be triggered by stressors such as exercise, nutritional deficits, and psychological stress. Dysfunction of the hypothalamic component of the reproductive axis plays a key role in functional HA and is manifest by an altered pattern of luteinizing hormone (LH) pulses detectable in peripheral blood. There is ample evidence supporting the use of LH as a surrogate marker of hypothalamic gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus. There is also significant evidence that women vary in their susceptibility to such stress-induced amenorrhea, pointing to a role for both environmental and genetic factors in the etiology of functional HA. However, the variation in changes in GnRH pulse frequency in response to stressors in healthy women has not been defined. Data from previous work in our lab has suggested that rare variants in genes associated with other forms of HH may also contribute to the variability seen in susceptibility to functional HA. The long-term goal of our research is to examine the interaction of environment and genes in HA. In this pilot study we propose to examine the inter-individual variability in pulsatile LH secretion in response to standardized neutral and deficient energy availability (NEA and DEA, respectively) in normal women. We will then relate this primary end-point to proposed predictive factors including past reproductive and family history and markers of current metabolic status and their response to energy availability. Our initial analyses will help to determine simplified biomarkers that can be translated to larger studies examining the potential combined effect of energy availability and genotype.
The proposed pilot study is a single-site, 2-period study in healthy female volunteers. The study will enroll approximately 300 participants with a target for study completion of 36 subjects. Eligible participants will be females \>= 18 years of age. Eligible participants will have had menarche at or before 14 years of age and no earlier than age 11. Eligible participants will have a gynecological age (years after menarche) of 14 years or less. The upper age limit will vary based on each subject s age of menarche and fall between 25 and 28 among participants. Eligible participants will confirm at the pre-screening call having normal menstrual cycles (self-reported) for at least the previous 2 months and ovulation will be confirmed during the menstrual cycle before the start of intervention.
The primary outcome will be changes in daytime LH pulse frequency, when comparing NEA vs DEA. Secondary measures will evaluate past reproductive history, family history, and current metabolic status using medical history interviews, lifestyle questionnaires and maximum oxygen uptake (as a measure of fitness). Resting energy expenditure, body composition as well as metabolic and stress hormones will be measured at baseline and in association with the interventions.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 38
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Experimental DEA All participants will be in the experimental arm and receive the DEA intervention. Control NEA All participants will receive the NEA availability to act as their own control to the experimental DEA intervention.
- Primary Outcome Measures
Name Time Method The primary outcome measure will be change in daytime LH pulse frequency following 5 days of neutral energy availability as compared to LH pulse frequency following 5 days deficient energy availability. LH pulse frequency. NEA Intervention Day 5 and DEA Intervention Day 5 Change in LH pulse frequency collected by sampling every 10 minutes over 8 hours during a study visit.
- Secondary Outcome Measures
Name Time Method Change in cortisol, TSH, TT3, and fT4 NEA Intervention Day 5 and DEA Intervention Day 5 Change in Laboratory Values collected by sampling over 8 hours during a study visit.
Change in hormone measures (LH, FSH, estradiol, and progesterone) from daily urine samples and blood spots, total cycle, follicular and luteal phase length during the cycle following NEA or DEA Menstrual cycle of the NEA Intervention and menstrual cycle of DEA Intervention Change in Laboratory Values during each menstrual cycle.
Change in leptin, ghrelin, adiponectin, insulin, and glucose in response to standardized breakfast, lunch, and snack NEA Intervention Day 5 and DEA Intervention Day 5 Change in Laboratory Values collected by sampling after standardized breakfast, lunch, and snack over 8 hours during a study visit.
Trial Locations
- Locations (1)
NIEHS Clinical Research Unit (CRU)
🇺🇸Research Triangle Park, North Carolina, United States